Targeting a specific interaction between tumor OTUD4 and CD73 to efficiently destabilize CD73 is an effective strategy for TNBC treatment, especially when combined with PD-L1 blockade, even in the case with abundant expression of tumor CD73 and OTUD4. Here, NT5E is linked to neoplasm.